Copyright Reports & Markets. All rights reserved.

Global Anti-Malarial Drug Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Anti-Malarial Drug Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Anti-Malarial Drug Market Size Growth Rate by Product
      • 1.4.2 Plasmodium Falciparum
      • 1.4.3 Plasmodium Vivax
      • 1.4.4 Plasmodium Malariae
      • 1.4.5 Plasmodium Ovale
    • 1.5 Market by End User
      • 1.5.1 Global Anti-Malarial Drug Market Size Growth Rate by End User
      • 1.5.2 Hospital Pharmacy
      • 1.5.3 Retail Pharmacy
      • 1.5.4 E-Commerce
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Anti-Malarial Drug Market Size
      • 2.1.1 Global Anti-Malarial Drug Revenue 2014-2025
      • 2.1.2 Global Anti-Malarial Drug Sales 2014-2025
    • 2.2 Anti-Malarial Drug Growth Rate by Regions
      • 2.2.1 Global Anti-Malarial Drug Sales by Regions
      • 2.2.2 Global Anti-Malarial Drug Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Anti-Malarial Drug Sales by Manufacturers
      • 3.1.1 Anti-Malarial Drug Sales by Manufacturers
      • 3.1.2 Anti-Malarial Drug Sales Market Share by Manufacturers
      • 3.1.3 Global Anti-Malarial Drug Market Concentration Ratio (CR5 and HHI)
    • 3.2 Anti-Malarial Drug Revenue by Manufacturers
      • 3.2.1 Anti-Malarial Drug Revenue by Manufacturers (2014-2019)
      • 3.2.2 Anti-Malarial Drug Revenue Share by Manufacturers (2014-2019)
    • 3.3 Anti-Malarial Drug Price by Manufacturers
    • 3.4 Anti-Malarial Drug Manufacturing Base Distribution, Product Types
      • 3.4.1 Anti-Malarial Drug Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Anti-Malarial Drug Product Type
      • 3.4.3 Date of International Manufacturers Enter into Anti-Malarial Drug Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Anti-Malarial Drug Sales by Product
    • 4.2 Global Anti-Malarial Drug Revenue by Product
    • 4.3 Anti-Malarial Drug Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Anti-Malarial Drug Breakdown Data by End User

    6 North America

    • 6.1 North America Anti-Malarial Drug by Countries
      • 6.1.1 North America Anti-Malarial Drug Sales by Countries
      • 6.1.2 North America Anti-Malarial Drug Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Anti-Malarial Drug by Product
    • 6.3 North America Anti-Malarial Drug by End User

    7 Europe

    • 7.1 Europe Anti-Malarial Drug by Countries
      • 7.1.1 Europe Anti-Malarial Drug Sales by Countries
      • 7.1.2 Europe Anti-Malarial Drug Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Anti-Malarial Drug by Product
    • 7.3 Europe Anti-Malarial Drug by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Anti-Malarial Drug by Countries
      • 8.1.1 Asia Pacific Anti-Malarial Drug Sales by Countries
      • 8.1.2 Asia Pacific Anti-Malarial Drug Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Anti-Malarial Drug by Product
    • 8.3 Asia Pacific Anti-Malarial Drug by End User

    9 Central & South America

    • 9.1 Central & South America Anti-Malarial Drug by Countries
      • 9.1.1 Central & South America Anti-Malarial Drug Sales by Countries
      • 9.1.2 Central & South America Anti-Malarial Drug Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Anti-Malarial Drug by Product
    • 9.3 Central & South America Anti-Malarial Drug by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Anti-Malarial Drug by Countries
      • 10.1.1 Middle East and Africa Anti-Malarial Drug Sales by Countries
      • 10.1.2 Middle East and Africa Anti-Malarial Drug Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Anti-Malarial Drug by Product
    • 10.3 Middle East and Africa Anti-Malarial Drug by End User

    11 Company Profiles

    • 11.1 GlaxoSmithKline
      • 11.1.1 GlaxoSmithKline Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 GlaxoSmithKline Anti-Malarial Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 GlaxoSmithKline Anti-Malarial Drug Products Offered
      • 11.1.5 GlaxoSmithKline Recent Development
    • 11.2 Ranbaxy
      • 11.2.1 Ranbaxy Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Ranbaxy Anti-Malarial Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Ranbaxy Anti-Malarial Drug Products Offered
      • 11.2.5 Ranbaxy Recent Development
    • 11.3 Zydus Cadila
      • 11.3.1 Zydus Cadila Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Zydus Cadila Anti-Malarial Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Zydus Cadila Anti-Malarial Drug Products Offered
      • 11.3.5 Zydus Cadila Recent Development
    • 11.4 Alvizia
      • 11.4.1 Alvizia Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Alvizia Anti-Malarial Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Alvizia Anti-Malarial Drug Products Offered
      • 11.4.5 Alvizia Recent Development
    • 11.5 Bayer
      • 11.5.1 Bayer Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Bayer Anti-Malarial Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Bayer Anti-Malarial Drug Products Offered
      • 11.5.5 Bayer Recent Development
    • 11.6 Ipca
      • 11.6.1 Ipca Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Ipca Anti-Malarial Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Ipca Anti-Malarial Drug Products Offered
      • 11.6.5 Ipca Recent Development
    • 11.7 Merck
      • 11.7.1 Merck Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Merck Anti-Malarial Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Merck Anti-Malarial Drug Products Offered
      • 11.7.5 Merck Recent Development
    • 11.8 F. Hoffmann-La Roche
      • 11.8.1 F. Hoffmann-La Roche Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 F. Hoffmann-La Roche Anti-Malarial Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 F. Hoffmann-La Roche Anti-Malarial Drug Products Offered
      • 11.8.5 F. Hoffmann-La Roche Recent Development
    • 11.9 Novartis
      • 11.9.1 Novartis Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Novartis Anti-Malarial Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Novartis Anti-Malarial Drug Products Offered
      • 11.9.5 Novartis Recent Development
    • 11.10 Pfizer
      • 11.10.1 Pfizer Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Pfizer Anti-Malarial Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Pfizer Anti-Malarial Drug Products Offered
      • 11.10.5 Pfizer Recent Development

    12 Future Forecast

    • 12.1 Anti-Malarial Drug Market Forecast by Regions
      • 12.1.1 Global Anti-Malarial Drug Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Anti-Malarial Drug Revenue Forecast by Regions 2019-2025
    • 12.2 Anti-Malarial Drug Market Forecast by Product
      • 12.2.1 Global Anti-Malarial Drug Sales Forecast by Product 2019-2025
      • 12.2.2 Global Anti-Malarial Drug Revenue Forecast by Product 2019-2025
    • 12.3 Anti-Malarial Drug Market Forecast by End User
    • 12.4 North America Anti-Malarial Drug Forecast
    • 12.5 Europe Anti-Malarial Drug Forecast
    • 12.6 Asia Pacific Anti-Malarial Drug Forecast
    • 12.7 Central & South America Anti-Malarial Drug Forecast
    • 12.8 Middle East and Africa Anti-Malarial Drug Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Anti-Malarial Drug Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Anti-malarial drugs (also called anti-malarials) are medications used for the treatment and prevention of malaria infection.
      On the one hand, they are used for routine intermittent treatment of specific groups in endemic regions. On the other, the drug can prevent the infection in individuals who travel or visit a malaria-endemic region
      The global Anti-Malarial Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Anti-Malarial Drug market based on company, product type, end user and key regions.

      This report studies the global market size of Anti-Malarial Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Anti-Malarial Drug in these regions.
      This research report categorizes the global Anti-Malarial Drug market by top players/brands, region, type and end user. This report also studies the global Anti-Malarial Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      GlaxoSmithKline
      Ranbaxy
      Zydus Cadila
      Alvizia
      Bayer
      Ipca
      Merck
      F. Hoffmann-La Roche
      Novartis
      Pfizer

      Market size by Product
      By meterial
      Plasmodium Falciparum
      Plasmodium Vivax
      Plasmodium Malariae
      Plasmodium Ovale
      By mechanism of action
      Resistance
      Prevention
      Market size by End User
      Hospital Pharmacy
      Retail Pharmacy
      E-Commerce
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Anti-Malarial Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Anti-Malarial Drug market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Anti-Malarial Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Anti-Malarial Drug submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Anti-Malarial Drug are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Anti-Malarial Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now